• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.12. 视网膜病变、神经病变与足部护理:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S252-S265. doi: 10.2337/dc25-S012.
2
7. Diabetes Technology: Standards of Care in Diabetes-2025.7. 糖尿病技术:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337/dc25-S007.
3
17. Diabetes Advocacy: Standards of Care in Diabetes-2025.17. 糖尿病倡导:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S335-S336. doi: 10.2337/dc25-S017.
4
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025.16. 医院中的糖尿病护理:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S321-S334. doi: 10.2337/dc25-S016.
5
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.2. 糖尿病的诊断与分类:《2025年糖尿病防治标准》
Diabetes Care. 2025 Jan 1;48(Supplement_1):S27-S49. doi: 10.2337/dc25-S002.
6
14. Children and Adolescents: Standards of Care in Diabetes-2025.14. 儿童和青少年:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S283-S305. doi: 10.2337/dc25-S014.
7
13. Older Adults: Standards of Care in Diabetes-2025.13. 老年人:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S266-S282. doi: 10.2337/dc25-S013.
8
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.1. 改善人群护理与促进健康:2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S14-S26. doi: 10.2337/dc25-S001.
9
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025.10. 心血管疾病与风险管理:2025年糖尿病护理标准。
Diabetes Care. 2025 Jan 1;48(Supplement_1):S207-S238. doi: 10.2337/dc25-S010.
10
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025.3. 糖尿病及相关合并症的预防或延缓:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S50-S58. doi: 10.2337/dc25-S003.

引用本文的文献

1
Prevalence of Peripheral Neuropathy Among Very Old Adults: Evidence From the Michigan Neuropathy Screening Instrument.高龄老年人外周神经病变的患病率:来自密歇根神经病变筛查工具的证据
J Am Geriatr Soc. 2025 Sep 1. doi: 10.1111/jgs.70041.
2
The Case for Primary Eye Care Integration in Community Health Centers.社区卫生中心开展初级眼保健整合服务的理由。
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251355047. doi: 10.1177/21501319251355047. Epub 2025 Aug 29.
3
Characteristics, Management, and Outcomes of Hospitalized Patients with Orthostatic Hypotension.体位性低血压住院患者的特征、管理及结局
J Clin Hypertens (Greenwich). 2025 Aug;27(8):e70118. doi: 10.1111/jch.70118.
4
Blood Cell Count-Based Inflammatory Markers Exhibit Superior Association with Diabetic Peripheral Neuropathy Compared to Protein-Based Markers.与基于蛋白质的标志物相比,基于血细胞计数的炎症标志物与糖尿病周围神经病变的关联更为显著。
J Inflamm Res. 2025 Aug 7;18:10609-10617. doi: 10.2147/JIR.S524220. eCollection 2025.
5
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
6
Fenofibrate and Diabetic Retinopathy.非诺贝特与糖尿病视网膜病变
Diabetes Ther. 2025 Sep;16(9):1763-1777. doi: 10.1007/s13300-025-01774-z. Epub 2025 Jul 30.
7
Estimating the Risk of Lower Extremity Complications in Adults Newly Diagnosed With Diabetic Polyneuropathy: Retrospective Cohort Study.新诊断为糖尿病性多发性神经病的成人下肢并发症风险评估:回顾性队列研究
JMIR Diabetes. 2025 May 29;10:e60141. doi: 10.2196/60141.
8
The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy.二肽基肽酶4抑制剂和胰高血糖素样肽-1受体激动剂在糖尿病周围神经病变中的治疗潜力
Diabetes Ther. 2025 Jun;16(6):1077-1105. doi: 10.1007/s13300-025-01712-z. Epub 2025 Mar 28.
9
Metabolomics in Pathogenic Pathways and Targeted Therapies for Diabetic Neuropathy: A Comprehensive Review.糖尿病神经病变致病途径与靶向治疗中的代谢组学:综述
Metabolites. 2025 Feb 1;15(2):86. doi: 10.3390/metabo15020086.
10
The Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy: New Lessons from Experimental Studies and Clinical Implications.炎症在糖尿病周围神经病变发病机制中的作用:来自实验研究的新认识及临床意义
Diabetes Ther. 2025 Mar;16(3):371-411. doi: 10.1007/s13300-025-01699-7. Epub 2025 Feb 10.

本文引用的文献

1
Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.胰高血糖素样肽-1受体激动剂暴露与眼压变化之间的关联:胰高血糖素样肽-1受体激动剂与眼压变化
Am J Ophthalmol. 2025 Jan;269:255-265. doi: 10.1016/j.ajo.2024.08.030. Epub 2024 Sep 3.
2
Effect of Fenofibrate on Progression of Diabetic Retinopathy.非诺贝特对糖尿病视网膜病变进展的影响。
NEJM Evid. 2024 Aug;3(8):EVIDoa2400179. doi: 10.1056/EVIDoa2400179. Epub 2024 Jun 21.
3
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.胰高血糖素样肽-1 受体激动剂与 2 型糖尿病患者青光眼风险的相关性。
Ophthalmology. 2024 Sep;131(9):1056-1063. doi: 10.1016/j.ophtha.2024.03.004. Epub 2024 Mar 13.
4
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.代谢综合征相关不明原因感觉周围神经病患者应用托吡酯的安全性和疗效:TopCSPN 随机临床试验。
JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711.
5
Artificial intelligence for telemedicine diabetic retinopathy screening: a review.人工智能在远程医疗糖尿病视网膜病变筛查中的应用:综述
Ann Med. 2023;55(2):2258149. doi: 10.1080/07853890.2023.2258149. Epub 2023 Sep 21.
6
Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review.新一代抗糖尿病药物对糖尿病视网膜病变的影响:批判性评价。
Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):717-752. doi: 10.1007/s00417-023-06236-5. Epub 2023 Sep 20.
7
Effects of exercise therapy on diabetic neuropathy: A systematic review and meta-analysis.运动疗法对糖尿病周围神经病变的影响:系统评价和荟萃分析。
Physiother Theory Pract. 2024 Sep;40(9):2116-2129. doi: 10.1080/09593985.2023.2227975. Epub 2023 Jun 21.
8
Fenofibrate for diabetic retinopathy.非诺贝特治疗糖尿病性视网膜病变。
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
9
Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update).糖尿病患者足部溃疡减压指南(IWGDF 2023 更新)。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3647. doi: 10.1002/dmrr.3647. Epub 2023 May 25.
10
Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review.糖尿病患者活动性夏科特神经关节病的诊断与治疗:一项系统评价
Diabetes Metab Res Rev. 2024 Mar;40(3):e3653. doi: 10.1002/dmrr.3653. Epub 2023 May 14.

12. 视网膜病变、神经病变与足部护理:2025年糖尿病护理标准

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.

出版信息

Diabetes Care. 2025 Jan 1;48(Supplement_1):S252-S265. doi: 10.2337/dc25-S012.

DOI:10.2337/dc25-S012
PMID:39651973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635040/
Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的《糖尿病护理标准》包含了ADA当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA专业实践委员会是一个跨专业专家委员会,其成员负责每年更新《护理标准》,如有必要,更新频率可更高。有关ADA标准、声明和报告的详细描述,以及ADA临床实践建议的证据分级系统和专业实践委员会成员的完整名单,请参阅引言和方法部分。希望对《护理标准》发表评论的读者可登录professional.diabetes.org/SOC进行评论。